Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Three Months Ended March 31,
Stock-based compensation 2023 2022
Cost of revenues $ 253  $ 46 
Sales and marketing 97  18 
General and administrative 859  472 
Research and development 153  28 
Total stock-based compensation $ 1,362  $ 564 
Summary of Restricted Stock Unit Activity
A summary of our restricted stock unit activity under the 2018 Plan for the three months ended March 31, 2023 is set forth below:
Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2022 2,957,995  $ 1.75 
Granted 2,293,704  0.92 
Released (1,221,562) 0.97 
Forfeited (20,500) 2.69 
Outstanding as of March 31, 2023 4,009,637  $ 1.37 
Summary of Stock Option Activity
A summary of our stock option activity under the 2018 Plan and related information is as follows:
Number of Shares Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(years)
Aggregate Intrinsic
Value
Outstanding as of December 31, 2022 87,500  $ 1.43  5.6 $ — 
Granted —  — 
Exercised —  — 
Forfeited —  — 
Outstanding as of March 31, 2023 87,500  $ 1.43  5.4 $ — 
Exercisable as of March 31, 2023 87,500  $ 1.43  5.4 $ — 
A summary of our option activity under the 2009 Plan and related information is as follows:
Number of Shares Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(years)
Aggregate Intrinsic
Value
Outstanding as of December 31, 2022 874,279  $ 0.80  4.2 $ 130 
Granted —  — 
Exercised (94,748) 0.61 
Forfeited —  — 
Outstanding as of March 31, 2023 779,531  $ 0.83  4.5 $ 73 
Exercisable as of March 31, 2023 779,138  $ 0.83  4.5 $ 73